LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Urine Osmolality Measurement Evaluated on Automated Analyzer

By LabMedica International staff writers
Posted on 06 Oct 2020
Image: The UF-5000 fully automated flow cytometer based on renowned fluorescence flow cytometry (FFC), represents the latest in urinalysis technology (Photo courtesy of Sysmex Corporation).
Image: The UF-5000 fully automated flow cytometer based on renowned fluorescence flow cytometry (FFC), represents the latest in urinalysis technology (Photo courtesy of Sysmex Corporation).
Urinalysis is a convenient and non‐invasive screening tool for use in both an outpatient and inpatient setting. Automated flow cytometry‐based urine analyzer is increasingly being used to identify and enumerate cells and particles in urine specimens. It measures electrical conductivity which could be transformed to osmolality.

The osmolality of urine, which indicates the quantity of osmotically active particles, can be estimated by the specific gravity (SG). While the SG correlates with urine osmolality, the direct measurement of urine osmolality is more accurate and is considered the gold standard for determining the hydration status of the body and its ability to concentrate urine.

Laboratory Medical Scientists at the Pusan National University Yangsan Hospital (Yangsan, South Korea) collected 270 random urine samples, also known as spot samples, for analysis that included osmolality testing from May 2018 to July 2018. The precision of urine osmolality measurement by the UF‐5000 (Sysmex Corporation, Kobe, Japan) was evaluated for 20 days and four times a day for two concentrations. The linearity and detection capability were evaluated according to the Clinical and Laboratory Standards Institute guidelines. A comparison analysis between the UF‐5000 and the OsmoPro equipment (Advanced Instruments, Norwood, MA, USA) was performed in the laboratory using random urine samples from patients.

The laboratorians reported that the laboratory‐based coefficient variations were less than 5%. Urine osmolality using the UF‐5000 has a verified linear range (R2 = 0.997). Within the comparison analysis, the mean difference was not large (−7.72%), but each differences were largely dispersed with 95% limits of agreement (LoA) from −70.5 to 55.06%, and the mean absolute difference −28.3 mOsm/kg with 95% LoA from −295.13 to 238.45 mOsm/kg. Cohen's kappa value was 0.54. The mean ± SD osmolality measured by the OsmoPro and UF5000 was 450.33 ± 227.51 mOsm/kg and 421.99 ± 221.53 mOsm/kg, respectively.

The authors concluded that the conductivity‐based measurement of osmolality has reliable precision and linearity within a specific range that includes the reference range. Considering the good accessibility of routine analyzer, UF‐5000 can be used to determine whether the urine osmolality is within the reference or should be measured by freezing depression method. The study was published on September 24, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Pusan National University Yangsan Hospital
Sysmex Corporation
Advanced Instruments


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gold Member
Collection and Transport System
PurSafe Plus®

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more